MedDataX Logo

Utility of Severity Scales in Clinical Practice in Children Hospitalized Due to Bronchiolitis.

NCT ID: NCT06737159

Last Updated: 2024-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-12-31

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective observational study of patients hospitalized with bronchiolitis. The objective of our study is to compare the accuracy of commonly used clinical scales for bronchiolitis to predict relevant outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchiolitis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

bronchiolitis bronchiolitis severity scoring validation utility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Children eligible for the trial must fulfil all of the following criteria:

1\. Children admitted to the hospital with the clinical diagnosis of acute bronchiolitis, which is defined as an apparent viral respiratory tract infection associated with airway obstruction manifested by at least one of following symptoms:

* Tachypnoea (WHO definition).
* Increased respiratory effort manifested as follows:

1. Nasal flaring;
2. Grunting;
3. Use of accessory muscles;
4. Intercostal and/or subcostal chest wall retractions;
5. Apnoe.
* Crackles and/or wheezing. 2. Aged 5 weeks - 24 months old.

Exclusion Criteria

1\. Diagnosis or suspicion of asthma.
Minimum Eligible Age

5 Weeks

Maximum Eligible Age

24 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Szpital im. Św. Jadwigi Śląskiej

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Szpital im. Św. Jadwigi Śląskiej

Trzebnica, , Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Henryk Szymański MD PhD

Role: CONTACT

Phone: 0048604467073

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Henryk Szymański, MD, PhD

Role: primary

Aleksandra Buczek, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4/PNDR/2023

Identifier Type: -

Identifier Source: org_study_id